Bluesight
Bluesight is a medication intelligence company providing RFID and AI-powered software to 3,000+ U.S. and Canadian hospitals for medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.
- Company typePrivate
- Founded2011
- HeadquartersAlexandria, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Bluesight does
Bluesight is a medication intelligence company founded in 2011 and headquartered in Alexandria, Virginia, that provides RFID and AI-powered software to 3,000+ hospitals and health systems across the United States and Canada. The company sells a unified suite of six core solutions: KitCheck (RFID-based medication inventory management for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance, including retail pharmacy), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-audit), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). The Prism AI Platform, launched in May 2026, layers natural language and generative AI capabilities across the suite, beginning with Prism Assistant inside ControlCheck. The underlying technology combines RFID hardware (tags and scanning stations) with cloud-based software that integrates data from EHRs, automated dispensing cabinets, wholesalers, controlled substance vaults, and HR systems, supported by proprietary behavioral and anomaly detection models and 20+ granted patents.
Bluesight operates a B2B enterprise SaaS business model, with annual subscriptions for software licenses and direct sales of RFID tags as a consumable hardware stream. The company goes to market through a direct enterprise field sales organization targeting pharmacy directors, CFOs, and compliance officers at hospitals and integrated delivery networks, supplemented by group purchasing organization contracts with Premier (national agreement effective May 2026), Vizient, HealthTrust, The Resource Group, and Advantus Health Partners. A direct e-commerce storefront sells KitCheck RFID tags online. Pricing is quote-based, varies by hospital size and module count, and is structured around bundled multi-module contracts with annual billing cycles. The company is private, backed by Thoma Bravo following a July 2023 strategic growth investment that also funded the acquisition of Medacist. Bluesight has since acquired Sectyr (October 2024) for 340B compliance expansion and Protenus (January 2025) for patient privacy capabilities, executing a roll-up strategy in hospital medication intelligence.
The company is led by Co-Founder and CEO Kevin MacDonald, with Mark Peters as CFO, Vijay Venkatesh as CTO, Jason Vander Meer as CPO, and Matt McAluney as CRO. Bluesight has earned 5x Best-in-KLAS recognition for Diversion Monitoring, 6x Best-in-KLAS for Patient Privacy Monitoring, and a MedTech Breakthrough Award, and operates the Bluesight Community across 2,200 hospitals for peer collaboration and product feedback that drives approximately 90% of new feature development.
Bluesight firmographics
Firmographics- Name
- Bluesight
- Legal name
- Bluesight, Inc.
- Website
- https://bluesight.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Bluesight is a medication intelligence company providing RFID and AI-powered software to 3,000+ U.S. and Canadian hospitals for medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.
- Ownership category
- akta.pro rank
Bluesight industry classification
Industry- Product category
- Hospital Pharmacy Intelligence Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- 340B Program Administration & Contract Pharmacy Services (HLAFALAL)
- akta.pro secondary industry
- Privacy Management (Consent, DSAR, RoPA) (HDADAFAH)
Keywords
Where Bluesight is headquartered
LocationHeadquarters
- HQ city
- Alexandria
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bluesight business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- SaaS Subscription — Software Licenses: Bluesight's primary revenue stream is recurring SaaS subscriptions for its suite of hospital intelligence software products (KitCheck, ControlCheck, CostCheck, 340BCheck, ShortageCheck, PrivacyPro). Customers access the platform on a per-subscription basis, with annual renewal cycles. The company markets bundled pricing, offering all six solutions under one vendor with 'bundled savings' and a single annual renewal.
- RFID Hardware — Tags and Scanning Stations: Bluesight sells RFID tags (1,000 per roll, with pricing per roll) and provides scanning stations (small, standard, mobile pharmacy cart, KitCheck Anywhere shelf liners) as part of its KitCheck offering. Scanning stations are provided at no cost to contracted customers, while tags are sold directly and through GPO contracts. Tag orders are processed via an order form on the Bluesight website.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription with modular product suite — pricing varies by hospital size, number of modules, and contract terms. |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Bluesight product offering
Product offeringCore offering
Bluesight sells a unified suite of hospital intelligence software for U.S. and Canadian hospitals and health systems, anchored by KitCheck (RFID medication tracking for kits, trays, and system-wide inventory), ControlCheck (AI-driven drug diversion surveillance), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-auditing), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring), all powered by the Prism AI platform. The company also sells RFID hardware (tags and scanning stations) and sells primarily through enterprise field sales and group purchasing organization (GPO) contracts with Premier, Vizient, HealthTrust, and others.
Product overview
Bluesight offers a unified suite of six core hospital intelligence solutions under its Medication Intelligence platform, powered by the Prism AI platform. The portfolio includes: KitCheck (RFID medication tracking for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance with retail pharmacy module), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance management), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). These solutions share a common data integration layer that connects fragmented data from wholesalers, health records, dispensing cabinets, and HR systems to provide unified operational visibility across hospital and pharmacy operations.
Differentiator
Problem solved
Functional benefit
Brands
- KitCheck: RFID medication tracking and inventory management solution for hospital kits, trays, and medication tracking
- ControlCheck
- CostCheck
- 340BCheck
- ShortageCheck
- PrivacyPro
- Prism
- KitCheck Anywhere
Products and services
- KitCheck Automated RFID-enabled medication management system for hospital kit and tray management, providing 100% accurate restocking 10x faster than manual alternatives. Used by over 1,000 hospitals to prevent medication waste, stockouts, and inaccuracies in OR anesthesia, crash carts, and procedural kits.
- ControlCheck Drug diversion surveillance software providing controlled substance monitoring across nursing, OR, inpatient pharmacy, and retail pharmacy operations. A 5x Best-in-KLAS winner that detects drug diversion 6.6x more effectively than other solutions, using the proprietary IRIS scoring system and closed-loop dose reconciliation that auto-reconciles 95% of controlled substance transactions.
- CostCheck Pharmacy cost optimization platform that helps hospitals eliminate approximately 4% of annual drug spend by providing actionable insights and tailored savings opportunities across all classes of trade, with integration to ShortageCheck for supply stability in procurement decisions.
- 340BCheck 340B compliance software designed as a compliance command center bringing 340B activity and data into one place, providing 100% self-auditing capabilities across patient, provider, and location — not just samples — with workflows designed around HRSA audit requirements and daily OPAIS sync.
- ShortageCheck Drug shortage management software using predictive analytics to forecast supply chain disruptions up to 90 days ahead, combining market intelligence from 3,250+ healthcare organizations (including fulfillment delays, demand surges, and usage trends) with collaborative planning tools for proactive shortage management.
- PrivacyPro Patient privacy monitoring solution that audits up to 100% of system accesses with 95–96% accuracy, using machine learning and Multi-Incident Patient Privacy Cases to detect privacy violations and enable compliance teams to uncover hidden breaches before they escalate. Achieves up to 70% time savings compared to legacy systems. A 6x Best-in-KLAS winner for Patient Privacy Monitoring.
- Prism AI platform built specifically for hospital pharmacy and compliance teams. Prism Assistant uses natural language processing to query controlled substance data and behavioral insights, reducing investigative task time by up to 97% (from 30 minutes to under 1 minute for variance analysis) and generating structured, evidence-backed answers in under 60 seconds.
- KitCheck RFID Tags and Scanning Stations RFID tags (1,000 per roll) sold directly to hospitals via the Bluesight website order form and through GPO purchasing channels, along with RFID scanning stations (small, standard, mobile pharmacy cart, and KitCheck Anywhere shelf-liners) provided as part of the KitCheck offering. Scanning stations are provided at no cost to contracted customers; tags are sold directly with standard, two-day, or overnight shipping.
Quantifiable outcome
- KitCheck delivers 100% accurate restocking, 10x faster than manual processes, and reduces medication waste by up to 92%
- +7 more outcomes
Companies that use Bluesight
Customer profileNamed customers8 records
Segments1 record
Ideal customer profiles1 record
Bluesight technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
AI capability9 records
Feature7 records
Bluesight partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, strategic and minor.
- Premier, Inc.coreBluesight was awarded a national group purchasing agreement with Premier, Inc. for Pharmacy Technology Solutions, effective May 1, 2026. Premier members can access Bluesight's full suite of solutions—including drug diversion surveillance, purchasing optimization, 340B compliance, shortage management, RFID inventory management, and patient privacy monitoring—at pre-negotiated pricing. This formalizes and expands a relationship spanning more than a decade.
- GraphiteRxstrategicBluesight announced a strategic partnership with GraphiteRx to integrate marketplace data—including Mark Cuban Cost Plus Drugs pricing—into Bluesight's hospital procurement tools (CostCheck and ShortageCheck). This integration helps hospitals reduce drug costs and manage shortages by expanding access to alternative medication sources.
- Pharmaceutical Logistics CompaniesminorBluesight announced strategic collaborations with pharmaceutical logistics and manufacturers at the 2025 ASHP Midyear Clinical Meeting to improve pharmacy operations and compliance, following a year of record growth, strategic partnerships, and product innovation.
- NXP SemiconductorsstrategicNXP Semiconductors collaborates with Bluesight (Kit Check deployed in over 900 U.S. hospitals) along with other healthcare ecosystem partners to deploy RFID and NFC technologies for patient safety, inventory management, and item-level traceability. NXP's RAIN RFID and NFC technologies enable bulk reading of medical supplies at speeds exceeding 1,000 items per second with 99.9% accuracy.
- 503B Outsourcing Facilities & Pharmaceutical Manufacturers (KitCheck Tagging Partners)strategicBluesight has partnered with 503B outsourcing facilities and pharmaceutical manufacturers to offer pre-tagged RFID medications that scan right out of the box. Partners include Fagron, Leiters, Nephron 503B Outsourcing Facility, QuVa, SCA Pharma, and Wells Pharma. This enables hospitals to use RFID-tagged medications without in-house tagging, reducing implementation friction for KitCheck.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Bluesight competitors and assessment
Company assessmentDirect peers
- Surescripts: Surescripts operates the dominant U.S. health information network for prescriptions, providing clinical intelligence, benefit transparency, and medication-related data services to hospitals and pharmacies. Its network breadth and clinical data assets are comparable to Bluesight's hospital intelligence data layer.
- symplr: symplr is a healthcare governance, risk, and compliance platform offering provider credentialing, contract management, and 340B-related solutions — directly overlapping with Bluesight's 340BCheck and broader compliance suite. Both sell multi-module compliance software to hospital systems and IDNs.
- Omnicell: Omnicell is a leading provider of medication management and pharmacy automation solutions for hospitals, directly competing with Bluesight in RFID-enabled kit/tray management, controlled substance tracking, and pharmacy analytics. Both serve the same acute-care pharmacy buyer with overlapping drug diversion and inventory capabilities.
- Imprivata: Imprivata provides identity, access management, and patient privacy monitoring solutions to hospitals, directly competing with Bluesight's PrivacyPro in healthcare privacy surveillance and access auditing. Both target healthcare compliance teams with ML-driven monitoring of EHR access events.
- Macro Helix: Macro Helix is a specialized provider of 340B compliance, split-billing, and pharmacy management software, directly competing with Bluesight's 340BCheck module. Both serve the same HRSA-audit-driven buyer at hospitals and contract pharmacies.
Broad incumbents
- McKesson Corporation: McKesson is a major drug distributor and healthcare IT provider whose pharmacy services and analytics offerings (including its US Oncology/Prescription Technology Solutions business) overlap with Bluesight's CostCheck purchasing optimization and ShortageCheck drug shortage products.
- Cardinal Health: Cardinal Health is a top-tier pharmaceutical distributor with a portfolio that includes hospital pharmacy solutions, inventory management, and 340B services (through its Cordavis biosimilar venture and consulting). It is a partial competitor and partner in Bluesight's drug purchasing ecosystem.
- Becton, Dickinson and Company (BD): BD's Medical and Pharmaceutical Systems segments supply medication management solutions including automated dispensing cabinets, pharmacy workflow software, and drug tracking hardware. BD overlaps with Bluesight in hospital medication inventory and controlled substance management, but as part of a much broader med-tech portfolio.
- Cencora (formerly AmerisourceBergen): Cencora is one of the largest U.S. pharmaceutical distributors and offers hospital pharmacy services and data/analytics tools. Its World Courier, consulting, and biopharma services businesses intersect with Bluesight's drug procurement and shortage management offerings, though Cencora's reach is much broader.
Emerging players
- Veeva Systems: Veeva is a leading vertical SaaS provider in life sciences and increasingly in healthcare, with Vault applications covering compliance, quality, and data management. While primarily life-sciences-focused, Veeva's compliance and quality suite serves a comparable hospital compliance buyer profile and represents a benchmark for vertical SaaS expansion playbooks.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bluesight social profiles
Digital presenceBluesight compliance and trust
Trust signalCompliance1 record
Bluesight financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bluesight leadership team
Management profileNumber of profiles
Profiles10 records
Bluesight subsidiaries and ownership
Company hierarchySubsidiaries3 records
Bluesight funding detail
Funding detailFunding overview
Funding rounds6 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bluesight M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bluesight
What does Bluesight do?
Bluesight sells a unified suite of hospital intelligence software for U.S. and Canadian hospitals and health systems, anchored by KitCheck (RFID medication tracking for kits, trays, and system-wide inventory), ControlCheck (AI-driven drug diversion surveillance), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-auditing), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring), all powered by the Prism AI platform. The company also sells RFID hardware (tags and scanning stations) and sells primarily through enterprise field sales and group purchasing organization (GPO) contracts with Premier, Vizient, HealthTrust, and others.
Is Bluesight a public or private company?
Bluesight is a private company. It is classified as private equity controlled and is currently operating.
When was Bluesight founded?
Bluesight was founded in 2011. It employs 101 to 250 people.
Where is Bluesight based?
Bluesight is headquartered in Alexandria, United States, in the North America region.
How does Bluesight make money?
Two revenue lines are on record. SaaS Subscription — Software Licenses are the primary driver. The others are RFID Hardware — Tags and Scanning Stations.
Who are Bluesight's main competitors?
Direct peers on record are Surescripts, symplr, Omnicell, Imprivata and Macro Helix. Broad incumbents are McKesson Corporation, Cardinal Health, Becton, Dickinson and Company (BD) and Cencora (formerly AmerisourceBergen). Veeva Systems is listed as an emerging player.
Does Bluesight have an API?
No public API is recorded for Bluesight.
What industry is Bluesight in?
Bluesight's product category is Hospital Pharmacy Intelligence Software. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HDADAFAH, Privacy Management (Consent, DSAR, RoPA). Its NAICS code is 5132 and its SIC code is 8000.